We obtained summary judgment on behalf of Change Healthcare and related entities in federal court litigation in Seattle stemming from Change Healthcare’s acquisition of a start-up business in the healthcare technology industry where the stock purchase agreement had contingent earn-out provisions. The former shareholders of the start-up business alleged, among other claims, breach of the implied covenant of good faith and fair dealing and breach of contract under Delaware law. Representative matters include: Lilly v. Envoy, LLC, No. C15-0742RSM, 2016 WL 7375271 (W.D. Wash. Dec. 20, 2016).
Change Healthcare (formerly NYSE: EM) is a leading provider of software and analytics, network solutions and technology-enabled services that optimize communications, payments and actionable insights designed to enable smarter healthcare.